Amdl News (AMEX:ADL)
| Latest Amdl News Headlines | | Date | Time | Source | | | 05/15/2008 | 11:49PM | PRNUS | AMDL Announces First Quarter 2008 Results Posting Sales of $3.58 Million
- Revenues from Product Sales Increased 149% to $3.5 Million -
TUSTIN, Calif., May 15 /PRNewswire-FirstCall/ -- AMDL, Inc. (AMEX:ADL) is a vertically integrated specialty pharmaceutical company headquartered in Tustin, California, with operations in Shenzhen, Jiangxi and Jilin China. Through its wholly owned subsidiary... More...>> |
| 05/14/2008 | 7:55PM | PRNUS | AMDL Subsidiary Donates Pharmaceuticals in China Earthquake Relief Effort
TUSTIN, Calif., May 14 /PRNewswire-FirstCall/ -- AMDL, Inc. (AMEX:ADL), headquartered in Tustin, California, with operations in Shenzhen, Jiangxi, and Jilin, China, is a vertically integrated specialty pharmaceutical company. Along with its subsidiary Jade Pharmaceutical Inc. (JPI), AMDL engages in the research, development... More...>> |
| 05/09/2008 | 11:47PM | PRNUS | AMDL Reports Going Concern Qualification
TUSTIN, Calif., May 9 /PRNewswire-FirstCall/ -- AMDL, Inc. (AMEX:ADL), an international vertically integrated specialty pharmaceutical company with operations in China through its wholly owned subsidiary, Jade Pharmaceutical Inc., today announced that its consolidated financial statements for the year ended December... More...>> |
| 05/07/2008 | 9:00AM | PRNUS | AMDL Signs Letter of Intent to Purchase a China Based Pharmaceutical Distribution Company
TUSTIN, Calif., May 7 /PRNewswire-FirstCall/ -- AMDL, Inc. (AMEX:ADL), headquartered in Tustin, California, with operations in Shenzhen, Jiangxi, and Jilin, China, is a vertically integrated specialty pharmaceutical company. In combination with its subsidiary Jade Pharmaceutical Inc. (JPI), the Company engages in the... More...>> |
| 04/30/2008 | 9:00AM | PRNUS | AMDL Signs MOU for 200 Store Distribution Arrangements for Goodnak Product Line
TUSTIN, Calif., April 30 /PRNewswire-FirstCall/ -- AMDL, Inc. (AMEX:ADL), headquartered in Tustin, California, with operations in Shenzhen, Jiangxi, and Jilin, China, is a vertically integrated specialty pharmaceutical company. In combination with its subsidiary Jade Pharmaceutical Inc., (JPI), the Company engages in... More...>> |
| 04/25/2008 | 2:29PM | PRNUS | The Rudd Report, Dated April 18, 2008, Updates AMDL's Recent Achievements
TUSTIN, Calif., April 25 /PRNewswire-FirstCall/ -- AMDL, Inc. (AMEX:ADL), an international biopharma company with development and manufacture of proprietary pharmaceutical and diagnostic products in China, announced today that a 4th Quarter Update and Year End Report on AMDL has been posted by analyst Lauren Rudd at... More...>> |
| 04/03/2008 | 5:00AM | PRNUS | AMDL Signs Exclusive Licensing Agreement for Human Papilloma Virus Diagnostic Test Kit in Certain Asian Countries
TUSTIN, Calif., April 3, 2008 /PRNewswire-FirstCall/ -- AMDL, Inc. (AMEX:ADL), headquartered in Tustin, California, with operations in Shenzhen, Jiangxi, and Jilin, China, is a vertically integrated specialty pharmaceutical company. In combination with its subsidiary Jade Pharmaceutical Inc. ("JPI"), AMDL engages in... More...>> |
| 04/01/2008 | 5:00AM | PRNUS | AMDL Reports 2007 Financial Results and 2008 Operating Strategy
TUSTIN, Calif., April 1, 2008 /PRNewswire-FirstCall/ -- AMDL, Inc. (AMEX:ADL), headquartered in Tustin, California, with operations in Shenzhen, Jiangxi, and Jilin, China, is a vertically integrated specialty pharmaceutical company. In combination with its subsidiary Jade Pharmaceutical Inc. (JPI), the Company engages... More...>> |
| 02/25/2008 | 8:46AM | PRNUS | AMDL Launches New Updated Website at www.amdl.com
TUSTIN, Calif., Feb. 25 /PRNewswire-FirstCall/ -- AMDL, Inc. (AMEX:ADL), headquartered in Tustin, California, with operations in Shenzhen, Jiangxi, and Jilin, China, through its wholly owned subsidiary Jade Pharmaceutical Inc., is an international biopharma company that, together with Jade, engages in the development... More...>> |
| 02/04/2008 | 9:20AM | PRNUS | AMDL Receives a Significant Updated Appraisal of Its JJB China Production Facilities
TUSTIN, Calif., Feb. 4 /PRNewswire-FirstCall/ -- AMDL, Inc. (AMEX:ADL), headquartered in Tustin, California, with operations in Shenzhen, Jiangxi, and Jilin, China, through its wholly owned subsidiary Jade Pharmaceutical Inc. (JPI), is an international biopharma company that, together with Jade, engages in the development... More...>> |
| 01/30/2008 | 9:00AM | PRNUS | AMDL Wins Chinese Military Supply Agreement for Its Domperidone Product for up to $6.6 Million
TUSTIN, Calif., Jan. 30 /PRNewswire-FirstCall/ -- AMDL, Inc. (AMEX:ADL), headquartered in Tustin, California, with operations in Shenzhen, Jiangxi, and Jilin, China, through its wholly owned subsidiary Jade Pharmaceutical Inc., (JPI) is an international biopharma company that, together with JPI, engages in the development... More...>> |
| 01/25/2008 | 8:15AM | PRNUS | AMDL Signs 100 Strategic Cooperation Agreements in China for Its JPGreen Clinics; Gross Sales Per Each Location Could Exceed $40
TUSTIN, Calif., Jan. 25 /PRNewswire-FirstCall/ -- AMDL, Inc. (AMEX:ADL), headquartered in Tustin, California, with operations in Shenzhen, Jiangxi, and Jilin China, through its wholly owned subsidiary Jade Pharmaceutical Inc., is an international biopharma company that, together with Jade, engages in the development... More...>> |
| 12/24/2007 | 3:00PM | PRNUS | AMDL Announces Closing of Private Offering
TUSTIN, Calif., Dec. 24 /PRNewswire-FirstCall/ -- AMDL, Inc. (AMEX:ADL), developer and marketer of tests for the early detection of cancer and other serious diseases, announced today that it has conducted the closing of its combined Regulation D/Regulation S private unit offering of 2,007,508 shares of common stock... More...>> |
| 12/19/2007 | 5:00AM | PRNUS | AMDL's First Full Service JPGreen Health and Personal Care Center Set to Open in Hangzhou, China
TUSTIN, Calif., Dec. 19 /PRNewswire-FirstCall/ -- AMDL, Inc., (AMEX:ADL), today announced that its subsidiary, Jade Pharmaceutical Inc., a developer, manufacturer, and marketer of pharmaceutical, nutraceutical, diagnostic, consumer healthcare and personal care products, is set to open its first large-scale JPGreen Health... More...>> |
| 11/30/2007 | 6:00AM | PRNUS | Savannah Capital Management Announces 3rd Quarter Report on AMDL (AMEX: ADL)
SARASOTA, Fla., Nov. 30 /PRNewswire/ -- Savannah Capital Management, Inc. is pleased to announce that its research department has just released the latest Rudd Report on the 3rd quarter results for AMDL (AMEX:ADL), Tustin, CA, an international biopharma company with significant development, manufacturing and marketing... More...>> |
| 11/29/2007 | 1:27PM | PRNUS | AMDL's Chinese Subsidiary Wins Key Brand Excellence Award for Anti-Aging Treatment
TUSTIN, Calif., Nov. 29 /PRNewswire-FirstCall/ -- AMDL, Inc. (AMEX:ADL), headquartered in Tustin, California, with operations in Shenzhen, Jiangxi and Jilin China, through its wholly owned subsidiary Jade Pharmaceutical Inc. (Jade), is an international biopharma company and today announced that Jade has received the... More...>> |
| 11/23/2007 | 1:12AM | PRNUS | AMDL Presentation of China Success Story from Rodman & Renshaw Annual Healthcare Conference Available at WallStreetReporter.com
TUSTIN, Calif., Nov. 23 /PRNewswire-FirstCall/ -- AMDL, Inc. (AMEX:ADLAMEX:-AMEX:News), headquartered in Tustin, California, with operations in Shenzhen, Jiangxi and Jilin, China, through its wholly owned subsidiary Jade Pharmaceutical Inc. (JPI), is an international biopharma company that engages in the development... More...>> |
| 11/20/2007 | 6:13PM | PRNUS | AMDL Launches New JPGreen Business Strategy
TUSTIN, Calif., Nov. 20 /PRNewswire-FirstCall/ -- AMDL, Inc. (AMEX:ADL), with operations in Shenzhen, Jiangxi and Jilin, China, through its wholly owned subsidiary Jade Pharmaceutical Inc. (JPI), an international biopharma company that engages in the development, manufacture and marketing of proprietary pharmaceutical... More...>> |
| 11/19/2007 | 5:08PM | PRNUS | AMDL Announces Sales of $5.8 Million for Third Quarter 2007 Results
TUSTIN, Calif., Nov. 19 /PRNewswire-FirstCall/ -- AMDL, Inc. (AMEX:ADL), headquartered in Tustin, California, with operations in Shenzhen, Jiangxi and Jilin China, through its wholly owned subsidiary Jade Pharmaceutical Inc. (JPI), an international biopharma company, announced today that it generated sales of approximately... More...>> |
| 11/13/2007 | 6:42PM | PRNUS | AMDL Announces Filing of Extension on Third Quarter 2007 Form 10-QSB
TUSTIN, Calif., Nov. 13 /PRNewswire-FirstCall/ -- AMDL, Inc. (AMEX:ADL) reported today that it has filed a Form 12b-25 with the Securities and Exchange Commission indicating that its Form 10-QSB for the six months ended September 30, 2007 would not be filed by November 14, 2007. However, AMDL expects to file the required... More...>> |
|
|
|